CALHM2 and Parkinson disease: Either conventional knockout of Calhm2 or microglial conditional knockout of Calhm2 rescued the MPTP-induced loss of tyrosine hydroxylase (TH)-positive neurons and inhibited neuroinflammation, thereby improving motor deficits in PD model mice.